Craif has developed a non-invasive platform for early cancer detection, employing advanced AI algorithms to analyze biological samples. The startup secured $22 million in funding to enhance its technology, aiming to significantly reduce cancer mortality rates. This has global implications for healthcare improvement and early diagnosis, especially in high-risk regions.
💰 Early Cancer Detection Startup Craif Raises $22M
